BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 14533729)

  • 21. Syringe exchange: HIV prevention, key findings, and future directions.
    Paone D; Des Jarlais DC; Gangloff R; Milliken J; Friedman SR
    Int J Addict; 1995; 30(12):1647-83. PubMed ID: 8557411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
    Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
    Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
    Costenbader EC; Zule WA; Coomes CC
    Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.
    Gostin LO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S60-70. PubMed ID: 9663626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Syringe and needle exchange programs: Part I.
    Schwartz RH
    South Med J; 1993 Mar; 86(3):318-22. PubMed ID: 8451672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of HIV infection among injection drug users in resource-limited settings.
    Vlahov D; Robertson AM; Strathdee SA
    Clin Infect Dis; 2010 May; 50 Suppl 3(Suppl 3):S114-21. PubMed ID: 20397939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The HIV-epidemic among drug addicts in Norway].
    Aavitsland P; Nilsen O; Lystad A
    Tidsskr Nor Laegeforen; 1996 Nov; 116(29):3502-5. PubMed ID: 9019859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of legalizing syringe exchange programs on arrests among injection drug users in California.
    Martinez AN; Bluthenthal RN; Lorvick J; Anderson R; Flynn N; Kral AH
    J Urban Health; 2007 May; 84(3):423-35. PubMed ID: 17265133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of effectiveness of targeted intervention program under national AIDS control program among injecting drug users across India.
    Sahu D; Ranjan V; Thakur N; Rai SK; Vardhana Rao MV
    Indian J Public Health; 2023; 67(2):247-253. PubMed ID: 37459020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.
    MacGowan RJ; Sterk CE; Long A; Cheney R; Seeman M; Anderson JE
    Int J Epidemiol; 1998 Apr; 27(2):302-8. PubMed ID: 9602414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to improve access to sterile syringes for injection drug users.
    Rich JD; Wolf FA; Macalino G
    AIDS Read; 2002 Dec; 12(12):527-35. PubMed ID: 12518719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syringe and needle exchange as HIV/AIDS prevention for injection drug users in Puerto Rico.
    Robles RR; Colón HM; Matos TD; Finlinson HA; Muñoz A; Marrero CA; García M; Reyes JC
    Health Policy; 1998 Sep; 45(3):209-20. PubMed ID: 10338952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverage to curb the emerging HIV epidemic among injecting drug users in Pakistan: delivering prevention services where most needed.
    Emmanuel F; Fatima M
    Int J Drug Policy; 2008 Apr; 19 Suppl 1():S59-64. PubMed ID: 18281206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Needle syringe acquisition and HIV prevention among injecting drug users: a treatise on the "good" and "not so good" public health practices in South Asia.
    Panda S; Sharma M
    Subst Use Misuse; 2006; 41(6-7):953-77. PubMed ID: 16809181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Torian LV; Beatice S; Semaan S; Friedman SR
    Drug Alcohol Depend; 2010 Jun; 109(1-3):154-60. PubMed ID: 20163922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Social context of needle selling in Baltimore, Maryland.
    Latkin CA; Davey MA; Hua W
    Subst Use Misuse; 2006; 41(6-7):901-13. PubMed ID: 16809178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.